ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1835

Microglial Defects Contribute to Neuropsychiatric Symptoms of Systemic Lupus Erythematosus

Hadijat Makinde1, Philip J. Homan2, Harris Perlman2 and Carla Cuda2, 1Northwestern University, Chicago, IL, 2Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Apoptosis, innate immunity and neuropsychiatric disorders, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Lupus Erythematosus – Animal Models

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Neuropsychiatric symptoms of systemic lupus erythematosus (NP-SLE), including headaches, cognitive dysfunction and psychiatric disorders, appear in up to 75% of SLE patients and may be among the earliest signs of SLE. However, these non-specific symptoms make diagnosis/treatment of NP-SLE problematic. Microglia are the resident innate immune cells in the brain and accumulating evidence points to this population as a source of neurotoxic factors that drive pathology of multiple neurodegenerative diseases. However, relatively little is known about microglia in the context of NP-SLE. We have shown that CD11c-specific deletion of caspase 8, an enzyme in the Fas pathway classically linked to apoptosis initiation and necroptosis suppression, induces a SLE-like disease that originates in part from heightened dendritic cell activation. We find that caspase 8 deletion extends to microglia, as these cells can express CD11c. To this end, we examined the neurological consequences of microglial caspase 8 deletion.

Methods: Mice with caspase 8 flanked by loxP sites (Casp8fl/fl, WT) were bred to mice expressing Cre under control of the CD11c gene promoter (CreCD11c) to generate CreCD11cCasp8flox/flox mice. Mice were subjected to a battery of tasks at Northwestern University’s Behavioral Phenotyping Core. MRI was performed at Northwestern University’s Center for Translational Imaging. Cellular infiltration into the brain was assessed using 10-color flow cytometric analysis. RNAseq analysis was performed on sorted microglia.

Results: With age, CreCD11cCasp8flox/flox mice develop an inflammatory disease reminiscent of both classic murine models of SLE and human SLE. Strikingly, CreCD11cCasp8flox/flox mice also exhibit neurological deficits during the Morris water maze, pre-pulse inhibition, contextual fear conditioning and rotarod tasks that indicate hippocampal and cerebellar abnormalities. Increased vascular permeability in CreCD11cCasp8flox/flox mice, as evidenced by Dynamic Intravascular Contrast Agent MRI, correlates with increased leukocyte infiltration seen by flow cytometric analysis. This infiltration resembles that of an acute model of traumatic brain injury, wherein physical damage to the brain promotes leakage of the blood-brain barrier. However, in our case, this breach is the direct result of CD11c-specific caspase-8 deletion and chronic systemic inflammation. GO analysis of differentially expressed genes reveals that transcriptional profiles of young caspase 8-deficient microglia are enriched for genes involved in amyloid precursor protein metabolic and catabolic processes and Notch receptor processing, while profiles of 10-12 month old caspase 8-deficient microglia are enriched for genes involved in inflammatory and immune responses.

Conclusion: These data substantiate a novel mechanism whereby caspase-8 controls microglial function at both early and late stages of SLE to prevent NP-SLE manifestations and highlight microglial defects as a potential mechanism underlying the pathogenesis of NP-SLE. We intend to leverage our transcriptional data to further interrogate how defective microglial function incites NP-SLE.


Disclosure: H. Makinde, None; P. J. Homan, None; H. Perlman, None; C. Cuda, None.

To cite this abstract in AMA style:

Makinde H, Homan PJ, Perlman H, Cuda C. Microglial Defects Contribute to Neuropsychiatric Symptoms of Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/microglial-defects-contribute-to-neuropsychiatric-symptoms-of-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microglial-defects-contribute-to-neuropsychiatric-symptoms-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology